◆ 会议时间：2021年11月4日至6日
◆ 会议地点：美国 奥兰多 - Orange County Convention Center, Orlando, Florida

◆ 会议简介：

2021年美国经导管心血管治疗学研讨会/大会(TCT)将于2021年11月4日至6日在美国佛罗里达州奥兰多举行。

TCT研讨会始于1988年，是美国心血管研究基金会(CRF)的年度科学研讨会，是世界上规模最大、最重要的专注于心血管介入医学的教育会议，每年都有来自世界各地的10000余名专业人士与会。30多年来，TCT通过提供前沿的教育内容、展示当前治疗和临床研究的最新进展，来提高目标受众群体的能力实践。TCT科学研讨会的与会者包括：介入心脏病专家、放射科医师、临床心脏病专家、科学家，血管医学专家、心脏和血管外科医生、护士、导管室技师和其他介入和血管医学领域的相关人士等。

美国心血管研究基金会(CRF)成立于1991年，是一个致力于改善世界各地心脏病患者生存和生活质量的非营利组织。CRF在介入心血管医学中安全地使用新技术、药物等手段治疗心脏与血管疾病方面发挥了重要的作用。CRF教育中心每年举办超过50个教育会议和大会，包括年度经导管心血管治疗（TCT）科学研讨会，为相关人员提供前沿技术和创新等方面的培训(未经本站许可，禁止复制摘录镜像本站任何内容-领域国际医学会议网)。

WHAT IS TCT?
The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease.lingyuint. For nearly 30 years, CRF has helped pioneer innovations in interventional cardiology and educated doctors on the latest treatments for heart disease.

Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Now in its 31st year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.

TCT 2021
Transcatheter Cardiovascular Therapeutics 2021
November 4-6, 2021
Orange County Convention Center
Orlando, Florida

Abstracts-摘要

Submit your abstracts of original research for the opportunity to present to thousands of your colleagues worldwide. Research can be in the form of clinical studies, basic science investigations, or preclinical studies and must be relevant to interventional cardiology, endovascular medicine, or structural heart disease. Your abstracts must convey original research but can include portions of previous abstracts and/or manuscripts presented elsewhere. Abstracts that are selected will be published in JACC. Note: Submit single-patient case reports to Challenging Cases, regardless of the novelty of the case.

Guidelines: Character limit is 2,200, including spaces (approximately 300-350 words).

Submission opens Tuesday, March 30, 2021
Submit by Tuesday, July 27, 2021 at 2:00 PM EDT (UTC -4)

View Guidelines and Submit Your Abstracts

Challenging Cases

Physicians and fellows from around the world, submit your most challenging coronary, endovascular, and structural heart disease cases. The best cases will be chosen by TCT 2021 course directors for presentation.

Guidelines: Character limit is 2,450 total for case summary, history, diagnostic tests, procedure, conclusion, comments. PowerPoint slide presentation highlighting your case is optional. Images: 10 MB. Video formats accepted: 30 MB mpeg, wmv, avi, mov, mpg, mp4

Submission opens Tuesday, April 6, 2021
Submit by Tuesday, June 29, 2021 at 2:00 PM EDT (UTC -4)

View Guidelines and Submit Your Challenging Cases

Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

Recognizing clinical and academic excellence in interventional cardiovascular medicine in physicians younger than 41 years of age (on November 4, 2021). Award recipient will receive a $10,000 USD scholarship.

Submission opens Tuesday, April 6, 2021
Submit by Tuesday, June 29, 2021 at 2:00 PM EDT (UTC −4)

View Guidelines and Submit Your Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award

TCT Innovation Sessions and TCT Shark Tank Innovation Competition

Innovation Sessions

Submit novel technologies relevant to the monitoring, diagnosis, and treatment of coronary, endovascular, or structural heart disease.

TCT Shark Tank Innovation Competition

Submit concept-stage novel technologies in interventional cardiovascular medicine — for a chance to present to a panel of expert judges and compete for $200,000 provided by the Jon DeHaan Foundation.

Submission opens Tuesday, March 30, 2021
Submit by Tuesday, July 27, 2021 at 2:00 PM EDT (UTC −4)

View Guidelines and Submit Entries to Innovation Sessions and/or Shark Tank Innovation Competition

Late-Breaking Clinical Trials and Science

Submission opens Tuesday, April 20, 2021
Submit by Thursday, August 19, 2021 at 2:00 PM EDT (UTC −4)

Late-Breaking Clinical Trials and Science are typically:

• First-time presentations of first-in-human experiences with novel devices or drugs
• Primary or important secondary endpoint results of prospective randomized clinical trials
• Large-scale, impactful single-/multicenter registries

Accepted submissions will be presented in the Main Arena at TCT 2021. In addition to being presented in the Main Arena, selected Late-Breaking Clinical Trials and Science are also selected for presentation during press conferences scheduled on the same day. Presentations of accepted late-breaking trials and science are strictly embargoed until time of presentation.

Please note that the following rarely qualify as late-breaking clinical trial submissions and instead, should be submitted as abstracts or to call for innovation: preclinical studies, early first-in-human device studies, and meta-analyses.

Guidelines: Total character limit is 3,250, including spaces (primary endpoints: 550 character limit; secondary endpoints: 550 character limit; funding sources: 500 character limit). Upload .png or .jpg files only.

TCT2021 注册费:

All figures are in U.S. dollars.

* Full Access is subject to availability.

Full Access

Includes:

• In-person attendance in Orlando, Florida, at the Orange County Convention Center, November 4–6, 2021. 
• Online access to all TCT 2021 content via livestream November 4–6, 2021.
• On-demand access for one year.

Online Access

Includes:

• Online access to all TCT 2021 content via livestream November 4–6, 2021.
• On-demand access for one year.

World Connect Satellites

Includes:

• Free online access to a wide range of educational satellite sessions broadcast live from World Connect studio at TCT 2021.
• Free on-demand access to all satellite sessions from TCT 2021.
• Free online access to the TCT 2021 Virtual Exhibit.

◆ 参会对象：
介入心脏病专家、放射科医师、临床心脏病专家、科学家，血管医学专家、心脏和血管外科医生、护士、导管室技师，以及其他介入和血管医学领域的相关专业人士等等。